Tiffen, Jessamy <br/><br/>
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma.  [electronic resource] 

 -  The Journal of investigative dermatology  12 2020 
 - 2442-2454.e5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1016/j.jid.2020.02.042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Line, Tumor<br/>Chromatin Immunoprecipitation Sequencing<br/>DNA Methylation--immunology<br/>Datasets as Topic<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--genetics<br/>Enhancer of Zeste Homolog 2 Protein--antagonists & inhibitors<br/>Female<br/>Gene Expression Regulation, Neoplastic--immunology<br/>Gene Silencing--immunology<br/>Humans<br/>Immune Checkpoint Inhibitors--pharmacology<br/>Interferon-alpha--genetics<br/>Interferon-gamma--genetics<br/>Melanoma--drug therapy<br/>Mice<br/>Mutation<br/>Neoplasm Invasiveness--genetics<br/>RNA-Seq<br/>Skin--immunology<br/>Skin Neoplasms--drug therapy<br/>Tumor Suppressor Proteins--genetics<br/>Xenograft Model Antitumor Assays